◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Rakovina Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 539,174 1.2M 1.2M 650,268 266,920 --
General And Administrative Expense 539,174 1.2M 1.2M 650,268 266,920 --
Research And Development 1.1M 1.6M 885,594 744,533 676,200 --
Operating Expense 1.6M 2.8M 2.1M 1.4M 943,120 --
Operating Income -1.6M -2.8M -2.1M -1.4M -943,120 --
EBIT -1.6M -2.8M -2.1M -1.4M -943,155 --
Interest Expense 139,752 91,688 66,779 69,084 67,986 --
Interest Expense Non Operating 139,752 91,688 66,779 69,084 67,986 --
Interest Income 0.00 0.00 0.00 0.00 437.00 --
Interest Income Non Operating 0.00 0.00 0.00 0.00 437.00 --
Net Interest Income -139,752 -91,688 -66,779 -69,084 -67,549 --
Other Income Expense -460.00 218.00 -2,698 -20,103 -472.00 --
Gain On Sale Of Security -460.00 218.00 -2,698 -1,288 -472.00 --
Pretax Income -1.8M -2.9M -2.2M -1.5M -1.0M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -1.8M -2.9M -2.2M -1.5M -1.0M --
Net Income From Continuing Operation Net Minority Interest -1.8M -2.9M -2.2M -1.5M -1.0M --
Net Income Including Noncontrolling Interests -1.8M -2.9M -2.2M -1.5M -1.0M --
Net Income Common Stockholders -1.8M -2.9M -2.2M -1.5M -1.0M --
Net Income -1.8M -2.9M -2.2M -1.5M -1.0M --
EBITDA -1.5M -2.7M -2.0M -1.3M -808,026 --
Normalized EBITDA -1.5M -2.7M -2.0M -1.3M -807,554 --
Reconciled Depreciation 135,129 133,660 132,191 135,129 135,129 --
Basic EPS -0.08 -0.18 -0.20 -- -0.11 -0.12
Diluted EPS -0.08 -0.18 -0.20 -- -0.11 -0.12
Basic Average Shares 21.1M 15.9M 14.1M -- 9.0M 7.1M
Diluted Average Shares 21.1M 15.9M 14.1M -- 9.0M 7.1M
Total Unusual Items -460.00 218.00 -2,698 -20,103 -472.00 --
Total Unusual Items Excluding Goodwill -460.00 218.00 -2,698 -20,103 -472.00 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -1.8M -2.9M -2.2M -1.5M -1.0M --
Diluted NI Availto Com Stockholders -1.8M -2.9M -2.2M -1.5M -1.0M --
Net Income Continuous Operations -1.8M -2.9M -2.2M -1.5M -1.0M --
Net Non Operating Interest Income Expense -139,752 -91,688 -66,779 -69,084 -67,549 --
Other Gand A 393,046 1.2M 1.1M 606,103 228,549 --
Rent And Landing Fees -- -- 8,291 7,908 7,939 8,297
Rent Expense Supplemental -- -- 8,291 7,908 7,939 8,297
Salaries And Wages 146,128 0.00 143,109 36,257 38,371 --
Total Expenses 1.6M 2.8M 2.1M 1.4M 943,120 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 822,293 1.9M 75,819 1.3M 255,049 --
Cash Cash Equivalents And Short Term Investments 822,293 1.9M 75,819 1.3M 255,049 --
Accounts Receivable 153,367 117,402 59,495 81,334 141,570 --
Receivables 153,367 117,402 59,495 81,334 141,570 --
Prepaid Assets 715,556 842,210 797,550 869,370 798,960 --
Current Assets 1.7M 2.8M 932,864 2.3M 1.2M --
Goodwill And Other Intangible Assets 3.6M 3.7M 3.8M 4.0M 4.1M --
Other Intangible Assets 3.6M 3.7M 3.8M 4.0M 4.1M --
Total Non Current Assets 3.6M 3.7M 3.8M 4.0M 4.1M --
Total Assets 5.3M 6.6M 4.8M 6.2M 5.3M --
Current Debt 1.4M 1.4M 1.4M 1.4M -- --
Current Debt And Capital Lease Obligation 1.4M 1.4M 1.4M 1.4M -- --
Accounts Payable 684,456 758,669 871,075 420,811 707,639 --
Payables 684,456 782,293 999,241 522,546 837,519 --
Payables And Accrued Expenses 743,101 808,118 999,241 522,546 837,519 --
Current Accrued Expenses 58,645 25,825 -- -- -- --
Current Liabilities 2.2M 2.2M 2.4M 1.9M 837,519 --
Long Term Debt 1.2M 1.1M -- -- 1.4M 1.4M
Long Term Debt And Capital Lease Obligation 1.2M 1.1M -- -- 1.4M 1.4M
Other Non Current Liabilities -1.00 -- -- -- -- --
Total Non Current Liabilities Net Minority Interest 1.2M 1.1M 0.00 0.00 1.4M --
Total Liabilities Net Minority Interest 3.4M 3.3M 2.4M 1.9M 2.2M --
Common Stock 18.5M 18.5M 16.5M 16.4M 14.8M --
Capital Stock 18.5M 18.5M 16.5M 16.4M 14.8M --
Additional Paid In Capital 5.2M 4.8M 3.1M 2.8M 1.7M --
Retained Earnings -21.8M -20.1M -17.2M -15.0M -13.5M --
Common Stock Equity 1.9M 3.2M 2.4M 4.3M 3.1M --
Stockholders Equity 1.9M 3.2M 2.4M 4.3M 3.1M --
Total Equity Gross Minority Interest 1.9M 3.2M 2.4M 4.3M 3.1M --
Total Capitalization 3.0M 4.3M 2.4M 4.3M 4.5M --
Net Tangible Assets -1.7M -495,612 -1.5M 321,442 -1.0M --
Tangible Book Value -1.7M -495,612 -1.5M 321,442 -1.0M --
Working Capital -489,280 622,851 -1.5M 321,442 358,060 --
Invested Capital 4.5M 5.7M 3.8M 5.7M 4.5M --
Total Debt 2.6M 2.5M 1.4M 1.4M 1.4M --
Net Debt 1.8M 647,106 1.3M 106,716 1.1M --
Share Issued 21.1M 21.1M 14.1M 14.0M 9.0M --
Ordinary Shares Number 21.1M 21.1M 14.1M 14.0M 9.0M --
Dueto Related Parties Current 0.00 23,624 128,166 101,735 129,880 --
Interest Payable 58,645 25,825 -- -- -- --
Other Current Borrowings 1.4M 1.4M 1.4M 1.4M -- --
Other Equity Interest 2,841 2,841 2,841 2,841 77,841 --
Tradeand Other Payables Non Current 40,500 -- -- -- -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -1.0M -3.0M -1.2M -1.8M -1.4M --
Cash Flow From Continuing Operating Activities -1.0M -3.0M -1.2M -1.8M -1.4M --
Depreciation And Amortization 135,129 133,660 132,191 135,129 135,129 --
Depreciation Amortization Depletion 135,129 133,660 132,191 135,129 135,129 --
Stock Based Compensation 380,699 0.00 217,345 16,155 18,212 --
Change In Working Capital 74,825 -302,341 570,354 -489,431 -556,880 --
Change In Receivables -35,965 -57,908 21,839 60,236 -101,403 --
Change In Payables And Accrued Expense -15,864 -199,773 476,695 -479,257 -208,855 --
Change In Payable -97,837 -199,773 476,695 -479,257 -208,855 --
Other Non Cash Items 83,166 38,817 23,009 43,631 22,193 --
Issuance Of Debt 0.00 -- -- 0.00 0.00 --
Net Issuance Payments Of Debt 0.00 -- -- 0.00 0.00 --
Issuance Of Capital Stock 60,957 -- -- 2.9M 600,000 --
Net Common Stock Issuance 60,957 -- -- 2.9M 600,000 --
Financing Cash Flow -25,393 -- -- 2.8M 265,213 --
Cash Flow From Continuing Financing Activities -25,393 -- -- 2.8M 265,213 --
Changes In Cash -1.1M 1.8M -1.2M 1.1M -1.1M --
Beginning Cash Position 1.9M 75,819 1.3M 255,049 1.4M --
End Cash Position 822,293 1.9M 75,819 1.3M 255,049 --
Free Cash Flow -1.0M -3.0M -1.2M -1.8M -1.4M --
Amortization Cash Flow 135,129 133,660 132,191 135,129 135,129 --
Amortization Of Intangibles 135,129 133,660 132,191 135,129 135,129 --
Change In Account Payable -97,837 -173,342 450,264 -451,111 -248,299 --
Change In Prepaid Assets 126,654 -44,660 71,820 -70,410 -246,622 --
Common Stock Issuance 60,957 -- -- 2.9M 600,000 --
Long Term Debt Issuance 0.00 -- -- 0.00 0.00 --
Net Income From Continuing Operations -1.7M -2.9M -2.2M -1.5M -1.0M --
Net Long Term Debt Issuance 0.00 -- -- 0.00 0.00 --
Net Other Financing Charges -86,350 -- -- -107,617 -334,787 --
NEWS
Loading news...
TRENDING
Loading...